By 2025, Luoyang will build a tens of billions of biological vaccine industry clusters

Innovation accelerate! The first genetic testing kit GMP R & D and production base in the province was put into operation in Luo Jiancheng. The total investment of the project plan is 120 million yuan, which will build an in vitro diagnostic kit from R & D, production, registration to listing and sales.

The carrier landed. Luoyang Hengnn Medical Inspection Labs has recently held a launching ceremony that can provide rich test items around clinical biochemical, clinical immunization, clinical microorganisms, etc., and plans to achieve more than 2,800 testing projects within 3 years.

The biomedical industry is the most active and far -reaching emerging industry in the 21st century innovation. According to the "Implementation Plan for the Development of the Biological Vaccine Industry Cluster in Luoyang City", Luoyang will actively use the advantages of the Luoyang animal vaccine and diagnostic reagent industry, accelerate the establishment of the tens of billions of biological vaccine industry clusters, and promote the high -quality development of the biomedical industry.

By 2025, the overall industry scale will exceed 10 billion yuan

As the "key corner" on the nostalgia Henan territory, the provincial animal vaccine and pharmaceutical industry research institutes formed by Plekki biology are currently under construction. By fulfilling the construction of the P3 laboratory, the production and research institute will form a major support for the development and industrialization of new vaccines and industrialization of major animal diseases in the province, thereby promoting leapfrog development in the biomedical industry.

Aiming at the field of emergencies in infectious diseases, focusing on major industrial air outlets such as major animal epidemic vaccines, in vitro diagnostic reagents, testing medical equipment, Luoyang will adhere to technological innovation leadership and build a characteristic industrial cluster with important influence in the country, and strive to reach it. 2025-

The scale of the industry has continued to grow. The overall industry scale exceeded 10 billion yuan, with an average annual growth rate of 58%.

The development of new products made breakthroughs. Build 50 innovative platforms, and achieve new technologies breakthroughs and new product development in the aspects of major animal epidemic vaccine, pet vaccine, and large -ring lactatochemical chemical drugs.

The industrial chain is gradually improved. Biological product raw materials and inspection of medical equipment components, vaccines, diagnostic reagents and instruments, animal prevention and therapeutic drugs in the entire industry chain of the entire industry chain are complete.

The driving effect is significantly improved. Promote the biological vaccine industry to seize a larger market share in the country. The number of new employment in the entire industry has reached 3,000, and the total profit and taxation has exceeded 3 billion yuan.

Power -force biological products, animal vaccines, diagnostic reagents and instruments and other fields

Help "stabilize Chinese rice bowls", Huaqing Tianmu aims at the "card neck" link of the biological vaccine industry to adhere to independent innovation. At present, there have been more than four categories of more than ten products. The performance of each product has reached the international leading level, creating economy for users Effect tens of billions of yuan.

According to the "Plan", in the fields of biological products, animal vaccines, diagnostic reagents and instruments, prevention and therapeutic drugs, Luoyang will aim at the industrial air outlet and actively build tens of billions of industrial clusters.

In the field of biological products, accelerate the construction of Luoyang Biomedical Industrial Park, and actively develop cephalosporin, penicillin, anti -tumor, autoimmune and other drugs;

In the field of animal vaccines, the development of new generation of beast gene engineering vaccines and human beasts are developed, and new types of vaccines such as African swine fever, pendulous diseases, and high pathogenic bird flu in Africa are developed and industrialized.

In the field of diagnostic reagents and instruments, actively carry out the industrialization of strong specific, high sensitivity, high sensitivity, convenient and fast diagnostic technology, and related kits to promote the integration of biological detection technology and sensing, the Internet of Things, and big data technology;

In the field of prevention and therapeutic drugs, the new structure of large -cycle endone -specific drugs and the research and development investment in the treatment and prevention of drugs for the treatment of veterinary drugs is increased, and the level of veterinary drug research technology is improved.

Focus on 5 tasks such as strengthening the development of air outlet products

Focusing on the development of the biological vaccine industry, the "Plan" has determined five key tasks of strengthening the development of air outlet products, increasing investment promotion, accelerating key parks and project construction, and strengthening enterprise cultivation and promotion.

Among them, in terms of accelerating the construction of key parks and projects, the "Plan" has arranged a "task book" for promoting the biological vaccine industry in relevant counties and districts in Luoyang, including — —

The Pleco P3 laboratory and supporting facilities, and biological products were actively promoted and put into operation, focusing on promoting the implementation of projects such as the development of new intelligent nanomal drugs in the China Science and Technology Park, and the implementation of human vaccines and other projects to build animal vaccine and veterinary drug industry bases;

West Industry District focuses on promoting the standardized plant project of Luoyang Biomedical Industrial Park and the construction of the R & D and production base of Chinese Medical Medicine Cloud. Health and biological manufacturing industry base;

Luo Long District focuses on promoting the construction of the second phase of the modern biological industrialization base project and other projects, and promotes Leposon to create a tracking prevention-screening and diagnosis-precision therapy for animal health industry chain;

Xin'an County focuses on the construction of Heng En Biomedical Industrial Park and high -end medical equipment and equipment industrial parks, and builds a diagnostic reagent and high -end medical equipment and equipment industry base.

According to the "Plan", by 2025, Luoyang will implement 28 projects of more than 10 million yuan in the field of biological vaccine, with a total investment of 7.39 billion yuan.

Luo Bao Rong Media · Palm of Luoyang Client reporter Chen Xiwen/Picture

- END -